Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119317712 | 11931771 | 2 | F | 20160830 | 20160120 | 20160906 | EXP | GB-VIIV HEALTHCARE LIMITED-GB2016005480 | VIIV | 0.00 | F | Y | 82.00000 | KG | 20160906 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119317712 | 11931771 | 1 | PS | RETROVIR | ZIDOVUDINE | 1 | Oral | 500 MG, QD | 19655 | 500 | MG | QD | |||||||
119317712 | 11931771 | 2 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Oral | 400 MG, QD | 0 | 400 | MG | QD | |||||||
119317712 | 11931771 | 3 | SS | VIDEX | DIDANOSINE | 1 | Oral | 400 MG, QD | 0 | 400 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119317712 | 11931771 | 1 | HIV infection |
119317712 | 11931771 | 2 | HIV infection |
119317712 | 11931771 | 3 | HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119317712 | 11931771 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119317712 | 11931771 | Exposure during pregnancy | |
119317712 | 11931771 | Stillbirth |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119317712 | 11931771 | 1 | 200001 | 0 | ||
119317712 | 11931771 | 2 | 20000122 | 0 | ||
119317712 | 11931771 | 3 | 20040122 | 0 |